# Progesterone

## Crinone vaginal gel 8%

| TAH Drug Code      | [ECRI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ECRI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of disorders associated with progesterone deficiency, such as infertility due to inadequate luteal phase; for use during IVF, where infertility is mainly due to tubal, idiopathic or endometriosis linked sterility associated with normal ovulatory cycles.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Treatment of infertility due to inadequate luteal phase : one application (1.125 g 8 % gel) every day, starting after documented ovulation or arbitrarily on the day18 to day21 of the cycle. When used during in-vitro fertilisation, daily application of CrinoneR 8 % gel should be continued for 30 days if there is laboratory evidence of pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Undiagnosed vag bleeding, breast or genital organ malignancy, acute porphyria, thrombophlebitis, thromboembolic disorder, cerebral apoplexy, missed abortion. Lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Abdominal pain, perineal pain, headache, constipation, diarrhea, nausea, joint pain, depression, decreased libido, nervousness, somnolence, breast tenderness & pain, dyspareunia, nocturia, allergy, bloating, cramps, fatigue, pain, dizziness, vomiting, genital moniliasis & pruritus, aggressive reactions, forgetfulness, vag dryness, cystitis, UTI, vag discharge. Gastrointestinal: Abdominal pain (oral, 10% to 20%; vaginal gel, 5% to 12%; vaginal insert, 12% ), Constipation (vaginal gel, 27%; vaginal insert, 2% to 3% ), Nausea (oral, 8%; vaginal gel, 6% to 22%; vaginal insert; 7% to 8% ) Immunologic: Viral disease (oral, 7% to 12% ) Musculoskeletal: Cramp (vaginal gel, 15% to 26% ) Neurologic: Dizziness (oral, 15% to 24%; vaginal gel, 5% ), Headache (oral, 10% to 31%; vaginal gel, 13% to 19%, vaginal insert, 3% to 4% ), Sleep disorder (vaginal gel, 18% ), Somnolence (vaginal gel, 27% ) Psychiatric: Depression (oral, 19%; vaginal gel, 11% to 19% ), Feeling nervous (vaginal gel, 16% ), Mood swings (oral, 6%; vaginal gel, 22% to 23% ) Reproductive: Breast tenderness (oral, 16% to 27% ), Large breast (vaginal gel, 40% ), Pain, Post-oocyte retrieval (vaginal insert, 25% to 28% ), Pain of breast (oral, 6% to 16%; vaginal gel, 13% ), Perineal pain (vaginal gel, 17% ) Other: Fatigue (oral, 8% to 9%; vaginal gel, 21% to 22%; vaginal insert, 2% to 3% ) |
| Pregnancy          | Human Data Suggest Risk in 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/progesterone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

